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The streptococcal collagen-like proteins 1 and 2 (Scl1 and Scl2) are major surface
adhesins that are ubiquitous among group A Streptococcus (GAS). Invasive M3-type
strains, however, have evolved two unique conserved features in the scl1 locus: (i) an
IS1548 element insertion in the scl1 promoter region and (ii) a nonsense mutation within
the scl1 coding sequence. The scl1 transcript is drastically reduced in M3-type GAS,
contrasting with a high transcription level of scl1 allele in invasiveM1-type GAS. This leads
to a lack of Scl1 expression in M3 strains. In contrast, while scl2 transcription and Scl2
production are elevated in M3 strains, M1 GAS lack Scl2 surface expression. M3-type
strains were shown to have reduced biofilm formation on inanimate surfaces coated with
cellular fibronectin and laminin, and in human skin equivalents. Repair of the nonsense
mutation and restoration of Scl1 expression on M3-GAS cells, restores biofilm formation
on cellular fibronectin and laminin coatings. Inactivation of scl1 in biofilm-capable M28
and M41 strains results in larger skin lesions in a mouse model, indicating that lack of
Scl1 adhesin promotes bacterial spread over localized infection. These studies suggest
the uniquely evolved scl1 locus in the M3-type strains, which prevents surface expression
of the major Scl1 adhesin, contributed to the emergence of the invasive M3-type strains.
Furthermore these studies provide insight into the molecular mechanisms mediating
colonization, biofilm formation, and pathogenesis of group A streptococci.
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INTRODUCTION
Group A Streptococcus (GAS) or Streptococcus pyogenes is a human-specific Gram-positive
pathogen responsible for significant morbidity and mortality worldwide (Carapetis et al., 2005;
Sims Sanyahumbi et al., 2016). The clinical outcomes resulting from GAS infection range from
superficial pharyngitis and impetigo to severe life-threatening diseases, such as streptococcal toxic
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shock syndrome and necrotizing fasciitis, as well as post-
infectious sequelae, including rheumatic fever, rheumatic
heart disease, and post-streptococcal glomerulonephritis
(Cunningham, 2000). Historically, GAS has been a significant
cause of puerperal sepsis, scarlet fever, erysipelas, and pharyngitis
(Stevens and Kaplan, 2000). GAS strains are epidemiologically
subtyped based on nucleotide sequence variation at the 5′-end
of the emm gene, reflecting differences in the hypervariable
N-terminal region of the anti-phagocytic surface protein
M. Over 240 M-types have been identified (http://www.cdc.
gov/abcs/index.html), and certain M-types have been shown to
have nonrandom associations with specific disease outcomes
(Cunningham, 2000; Shulman et al., 2004). Since the 1980’s
there has been resurgence in invasive GAS diseases in the U.S.
and other parts of the world. Numerous epidemiology studies
conducted in the U.S. (Stevens et al., 1989; Musser et al., 1991;
Cleary et al., 1992; Johnson et al., 1992; DiPersio et al., 1996;
Cockerill et al., 1997), Canada (Davies et al., 1996; Kaul et al.,
1997; Sharkawy et al., 2002; Hollm-Delgado et al., 2005), and
Europe (Gaworzewska and Colman, 1988; Colman et al., 1993;
Lamagni et al., 2008; Meisal et al., 2010) have found associations
between infections with M1- and M3-type strains and invasive
diseases. Specifically, M3-type strains have been associated with
severe invasive disease (Musser et al., 1991; Lamagni et al., 2008)
and fatal outcomes (Gaworzewska and Colman, 1988; Colman
et al., 1993; Sharkawy et al., 2002).
These epidemiological observations have spurred significant
whole genome sequencing efforts aimed at identification of the
underlying genetic basis for virulence in M3-type GAS. The
complete annotated genomes of invasive M3 strains MGAS315
and SSI-1 have been reported (Beres et al., 2002; Nakagawa et al.,
2003). These studies have revealed that differing phage elements,
insertion sequences, and the large-scale chromosomal inversion
identified in SSI-1, contributed to much of the genetic variation
between M3 and other M-types. Acquisition of prophages and
SNP’s drive the expansion of different M3 subclones during
epidemic waves of infection (Beres et al., 2004, 2010). Strains
causing pharyngitis and those causing invasive infections are
derived from the same pool of M3 strains (Shea et al., 2011).
In addition, genetic variation in virulence regulators, including
RopB and CovRS, which are “hot-spots” for the accumulation
of mutations, also contributes to the hypervirulence of M3
strains (Beres et al., 2010; Carroll et al., 2011; Shea et al.,
2011; Olsen et al., 2012; Flores et al., 2013; Cao et al., 2014).
The cause of the hyper-invasive phenotype of M3 strains is
multifactorial and involves multiple virulence factors controlled
by complex regulatory networks that continually undergo
remodeling.
The streptococcal collagen-like proteins 1 and 2, or Scl1
and Scl2 (also known as SclA and SclB), are major GAS
surface adhesins known to contribute to pathogenesis. Both
Scl proteins contain an N-terminal variable region, followed
by a collagen-like region containing Gly-X-Y repeats and a
cell-wall-anchored C-terminal region (Lukomski et al., 2000,
2001; Rasmussen et al., 2000; Rasmussen and Björck, 2001;
Whatmore, 2001). Transcription of scl1 is positively regulated
by the multiple gene regulator Mga (Rasmussen et al., 2000;
Lukomski et al., 2001; Almengor and McIver, 2004). Scl1 binds
cellular fibronectin and laminin (Caswell et al., 2010), and
contributes to the formation of biofilm by strains of multiple
M-types (Oliver-Kozup et al., 2011, 2013). GAS adherence and
biofilm formation is enhanced on extracellular matrix (ECM)
coatings and on fibroblast-deposited ECM network (Lembke
et al., 2006; Oliver-Kozup et al., 2013), supporting a role for
Scl1 in tissue-microcolony formation described during GAS
skin infection (Akiyama et al., 2003). While the scl1 gene has
been found in every GAS strain tested (Lukomski et al., 2000;
Rasmussen et al., 2000), the scl1.3-allele in M3-type strains
harbors a null mutation within the coding sequence (Lukomski
et al., 2000). A rare natural reversion of this polymorphism was
identified in a small subset of M3 carrier strains (Flores et al.,
2015).
Scl2-protein expression is regulated during translation by
varying numbers of short CAAAA repeats downstream of the
start codon that determine whether the protein-coding sequence
is in-frame or translation will be prematurely terminated
(Lukomski et al., 2001; Rasmussen and Björck, 2001); genome
sequencing indicates majority of the M3-type strain contain
in-frame scl2.3 alleles (Beres et al., 2004; Meisal et al., 2010).
Scl2 has been shown in some strains to bind the human
thrombin-activatable fibrinolysis inhibitor (Påhlman et al.,
2007) and contribute to adherence to fibroblasts (Rasmussen
and Björck, 2001), although its role in GAS pathogenesis is
less understood. Recently, the crystal structure of the Scl2.3
globular domain, which is structurally conserved between Scl1
and Scl2, has been reported (Squeglia et al., 2013, 2014)
providing insight into the potential binding interactions with
host ligands.
In this study, we show that invasive M3-type GAS harbor
two unique conserved features of the scl1 locus including the
IS1548 insertion in the promoter region and the null mutation
in the coding sequence, which results in a secreted instead of
cell-attached Scl1 protein. We demonstrate significantly different
expression patterns of scl1 and scl2 in M3-type GAS compared
to representative strains of M1-, M28-, and M41-types. We
demonstrate that the expression of the Scl1 adhesin is deficient
in serotype M3 strains, as opposed to M1-, M28-, and M41-
type strains. However, the Scl2 protein is upregulated in M3
strains compared to M1, M28, and M41 GAS. The M3 strains
lacked significant biofilms on cellular fibronectin and laminin
coatings, compared to M41-type GAS, and did not form tissue
microcolonies in a wounded pseudo-organ skin equivalent model
of infection. Recombinant Scl1.3 specifically bound cellular
fibronectin and laminin, and restoration of surface expression
of Scl1.3 conferred significant biofilm formation by M3 strains.
Inactivation of Scl1 expression in biofilm-capable M28- and
M41-type GAS resulted in larger skin lesions produced by
the mutants in a mouse model of subcutaneous infection,
supporting a role for Scl1 in maintaining a localized infection.
Our model advocates that the lack of surface-associated Scl1
adhesin in M3-type strains causes decreased tissue adherence
and decreased capacity for stable microcolony formation,
thus, promoting bacterial spread over localized nidus of
infection.
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MATERIALS AND METHODS
Bacterial Strains and Growth
MGAS315 and MGAS10870 are fully sequenced invasive
M3-type strains (Beres et al., 2002, 2010). MGAS315 was isolated
from a patient with streptococcal toxic syndrome in the 1980’s
(Musser et al., 1991) andMGAS10870 was isolated from a patient
with soft tissue infection in Ontario in 2002 (Beres et al., 2010).
Additional strains from epidemiologically diverse M-types were
used for comparison: MGAS6183 (M41), MGAS5005 (M1), and
MGAS6143 (M28). The MGAS61431scl1-, MGAS61831scl1-,
and MGAS108701scl1-inactivated mutant strains have been
previously described (Han et al., 2006a; Caswell et al., 2007; Flores
et al., 2015). Group A Streptococcus cultures were grown in Todd-
Hewitt broth (Becton Dickinson and Co.) supplemented with
0.2% yeast extract (THY medium) and on Brain Heart Infusion
agar (Becton Dickinson and Co.) at 37◦C in an atmosphere with
5% CO2. For antibiotic selection, erythromycin (5µg mL−1),
chloramphenicol (10µg mL−1), kanamycin (200µg mL−1), and
spectinomycin (100µg mL−1) were added to the medium.
Cloning experiments were performed in XL-1 Blue and
TB1 E. coli cells, while protein expression experiments were
performed in BL21 and TB1 E. coli cells grown in Luria-
Bertani media (Difco Laboratories) at 37◦C. For antibiotic
selection, chloramphenicol (10µg mL−1), kanamycin (50µg
mL−1), spectinomycin (100µg mL−1), and ampicillin (100µg
mL−1) were added to the medium.
PCR Assays
Analytical PCR
Detection of IS element upstream of scl1 in GAS strains
The presence of IS1548 upstream of scl1 was determined by
PCR with primers IS1548F and Scl1R using Qiagen Taq DNA
polymerase (Qiagen, Germantown, MD) as follows: 95◦C, 5 min-
[95◦C 1min, 62◦C 1min, 72◦C 1min]× 30 cycles- 72◦C, 10min.
Sequences of primers used in all PCR assays are listed in Table S1.
PCR amplification of scl1.3 and scl2.3 alleles
PCR was performed on genomic DNA isolated from M3 strains
with primer pairs 232 Up/232 Rev for scl1.3 amplification
and sequencing, and Scl2.3 F/R and SclUp/SclRev for length
polymorphism analysis and sequencing of scl2.3, respectively.
Amplification was performed using Qiagen Taq DNA polymerase
as follows: scl1.3: 95◦C, 5min-[95◦C 1min, 55◦C 1min, 72◦C
1min] x30 cycles- 72◦C, 10min; scl2.3: 95◦C, 5min-[95◦C 1min,
51◦C 1min, 72◦C 1min 45 s]× 30 cycles- 72◦C, 10min. All PCR
products were analyzed in a 1% agarose gel with 1 kb Plus DNA
ladder as a molecular size marker (Life Technologies, Grand
Island, NY).
Quantitative Reverse Transcription PCR (qRT-PCR)
RNA isolation
Total RNA was isolated from the logarithmic phase (OD600
0.5) GAS cultures using RNeasy Protect Bacteria Mini kit
(Qiagen), employing an additional pretreatment step with
250µg lysozyme, 100µg proteinase K, and 12.5 U mutanolysin
per sample to augment cell wall disruption. Trace genomic
DNA was removed by incubation with TurboDNase enzyme
(Ambion). RNA quality was assessed in 1% agarose gel and
spectrophotometrically; A260/280 and A260/230 ratios of >1.8
were considered acceptable. RNA was used immediately in
cDNA synthesis or stored at −80◦C for no more than
1 week.
Determination of transcription by qRT-PCR
Synthesis of cDNA was performed using iScript Select cDNA
synthesis kit (Bio-Rad) with 1µg of RNA per reaction and
random primer mix. For each sample, a no reverse transcriptase
control was performed, containing only RNA, reaction buffer,
and random primer mix, to ensure the absence of genomic
DNA. Incubations were carried out on a Bio-Rad C1000 Touch
Thermal cycler: 25◦C 5min, 42◦C 30min, 85◦C 5min, and
cDNA was stored at −20◦C until used in qRT-PCR. qRT-
PCR reactions were performed with 250 nM primers using
SsoAdvanced SYBR Green Universal Supermix (Bio-Rad). For
each qRT-PCR reaction, template cDNA, diluted 1:20, control
genomic DNA, or no reverse transcriptase control were used.
PCR was performed using the following conditions on a Bio-
Rad CFX96 Thermal cycler: 95◦C 2min- [95◦C 5 s, 60◦C 30 s]
× 30- [65◦C − 95◦C, 5 s, 0.5◦C/step]. Standard curves were
generated for each primer set using cDNA from MGAS315
to determine the linear range and estimate reaction efficiency.
Gene expression of scl1, scl2, emm, and mga was normalized
against the expression of tufA gene, which has previously been
identified and validated as an appropriate endogenous control
(Virtaneva et al., 2005). The 11Ct method was utilized to
compare gene expression between MGAS315 and other M3
strains, as well as M1, M28, and M41-type strains. Data was
averaged from three independent experiments, each containing
three technical replicates. Statistical significance was determined
using an unpaired t-test.
Recombinant Scl (rScl) Proteins
Cloning, Expression, and Purification of M3-Derived
rScl Proteins
The rScl proteins were generated using the Strep-tag II cloning,
expression, and purification system (IBA-GmbH, Gottingen,
Germany). Proteins were expressed with a C-terminal affinity
tag and purified on Strep-Tactin sepharose, as described (Han
et al., 2006b). rScl proteins rScl1.3V and rScl1.3FL are derived
from MGAS315, whereas rScl2.3 protein is derived from the M3
strain MGAS3375. The recombinant Scl2.3V protein has been
described previously (Squeglia et al., 2013). Construct containing
the recombinant full-length Scl1.3FL (rScl1.3FL) protein was
previously described (Flores et al., 2015). Briefly, the scl1.3 coding
region from MGAS315 was cloned into the E. coli/GAS shuttle
vector pJRS525 (McIver and Scott, 1997), generating plasmid
pSL501. PCR mutagenesis was used to convert the internal TAA
stop codon into a GAA glutamate codon, resulting in plasmid
pSL502 with continuous full-length scl1.3FL allele. This sequence
was subsequently cloned into the pASK-IBA2 expression vector
for recombinant Scl1.3FL protein production; each clone was
verified by sequencing. Protein expression constructs are listed
in Table 1.
Protein expression was induced by the addition of
anhydrotetracycline at 0.2µg mL−1 for 3 h. Cells were
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TABLE 1 | Constructs used in this study.
Plasmid Description Source
pJRS525 E. coli / S. pyogenes shuttle vector McIver and Scott, 1997
pSL230 pJRS525 with scl1.41 allele Caswell et al., 2007
pSL501 pJRS525 with scl1.3WT allele Flores et al., 2015
pSL502 pSL501 with repaired allele scl1.3FL Flores et al., 2015
pSL518 pSL502 with KanR in place of SpcR This study
pASK-IBA2 E. coli expression vector IBA, Göttingen
pSL154 pASK-IBA2 encoding rScl1.3V This study
pSL503 pASK-IBA2 encoding rScl1.3FL Flores et al., 2015
pSL514 pASK-IBA2 with rScl2.3 This study
pSB027 GFP-encoding plasmid Cramer et al., 2003
centrifuged and resuspended in high sucrose buffer (100mM
Tris-HCl, 1mM EDTA, pH 8.0, 500mM sucrose) or Cell Lytic
B Buffer (Sigma), for separation of the periplasmic fraction and
subsequent affinity purification. Proteins were dialyzed against
25mMHEPES, pH 8.0, and analyzed by SDS-PAGE stained with
RAPIDstainTM (G-Biosciences). Protein sequence was confirmed
using mass spectrometry (University of Nebraska Medical
Center) and N-terminal Edman Degradation sequencing (Iowa
State University).
Electron Microscopy of Rotary Shadowed rScl
Proteins
Electron microscopy visualization of the rotary shadowed
preparations of rScl1.3FL and rScl2.3 was used to assess the
domain organization of rScl proteins, as employed previously
(Xu et al., 2002). The rScl proteins were dialyzed against
0.1M ammonium bicarbonate and mixed with glycerol to a
final concentration of 70% (vol:vol). Samples were nebulized
onto mica chips with an airbrush and rotary-shadowed with
carbon/platinum using an electron beam gun. Photomicrograph
images were acquired using a transmission electron microscope
FEI G2 operated at 80 KV.
Mass Spectrometry Analysis
Samples from in-gel trypsin digested proteins were cleaned using
a Millipore µC18 ZipTip, then resuspended in 0.1% formic acid.
Samples were fractionated on a Eksigent cHiPLC column (75µm
× 15 cm ChromXP C18-CL 3µm 120 Å), and resulting peptides
were sequenced using 5600 TripleTOF (typical gradient 2–60%
ACN in 60min). Peptides identified were searched against the
NCBI protein database with Protein Pilot software employing
the following settings: search effort, thorough; taxonomy, none.
Positive identification was considered as the identification of two
or more unique peptides at high confidence ≥95%, FDR = 0.05,
0.01, or 0.001, which matched the same protein entry in the
database searched.
Binding of rScl Proteins to Extracellular Matrix
Proteins and Synthetic Peptide
ELISA binding assays
Binding of rScl proteins to extracellular matrix proteins,
cellular fibronectin (cFn) and laminin (Lm), was tested by
ELISA (Caswell et al., 2010). rScl proteins were immobilized
onto Strep-Tactin R© coated microplate wells (IBA GmbH)
at 0.5µM at room temperature for 1.5 h, then blocked with
Tris-buffered saline (TBS) containing 1% bovine serum albumin
(BSA) overnight at 4◦C. The cellular fibronectin from human
foreskin fibroblasts (Sigma) and murine laminin (Invitrogen)
were added to the wells at 1µg per well and incubated at
room temperature for 1 h. Bound ECM proteins were detected
with rabbit anti-laminin at 1:100 (Sigma) and anti- human
fibronectin at 1:4000 (Sigma) polyclonal antibodies. Secondary
antibody goat anti-rabbit IgG (H+L) HRP conjugate (Bio-
Rad) was next used with 1-step ABTS substrate (2,2′-Azinobis
[3-ethylbenzothiazoline-6-sulfonic acid]-diammonium salt)
(ThermoScientific). Absorption was measured using Spectramax
190 at a wavelength of 415 nm. Statistical analysis is based on
three independent experiments each containing three technical
replicates, using an unpaired t-test.
In antibody inhibition assay, the IST-9 mAb targeting the
C-C′ loop of EDA domain was utilized (Oliver-Kozup et al.,
2013). cFn was either untreated or pre-treated with increasing
concentrations of IST-9 blocking mAb (0.1–1.0µg), and added
to Strep-Tactin R©-coated microplate wells immobilized with rScl
proteins, then incubated for 1 h. Bound ECM proteins were
detected as above.
Design and synthesis of the C-C′ cyclic peptide
The C-C′ cyclic peptide was designed based on the crystal
structure of the EDA domain of cFn (PDB code 1J8K). In
particular, the region, which was reported to be involved in Scl1
binding, connecting to two β-strands C and C′ of EDA was
elongated to the whole C-C′ β-hairpin by allowing the formation
the electrostatic interaction between Arg33 and Glu45. The
terminal Tyr32 and Pro48 were mutated to Cys to stabilize the β-
hairpin by introducing a disulfide bond (Figure S4). The obtained
sequence, CRVTYSSPEDGIHELFC (molecular weight: 1997.1
Da), endowed with a cyclic structure to mimic the structure
of this region in EDA, was acetylated and amidated at the N-
and C-terminus, respectively. Synthesis of the designed peptide
was performed employing the solid phase method on a 50µmol
scale initially following standard Fmoc strategies (Fields and
Noble, 1990). Due to aspartimide formation during traditional
acylation reactions, peptide synthesis was carried out employing
microwave technology (Vanier, 2013). Cyclization was achieved
by treating the peptide at 0.1mg/mL (to avoid intermolecular
disulphide formation) with buffer carbonate 50mM, pH =
9, overnight. The peptide was purified by RP-HPLC and
the identity and purity (>97%) was assessed by LC-MS
(data not shown).
Surface plasmon resonance (SPR) experiments
Real time binding assays were performed at 25◦C on a
Biacore 3000 Surface Plasmon Resonance (SPR) instrument (GE
Healthcare). For immobilization, rScl1.3FL protein containing
the C-terminal Strep-tag II was injected at a concentration of
40µM on streptavidin-coated sensor chip, SA Biacore, until the
desired level of immobilization was achieved (averaged value of
100 RU). Binding assays were carried out by injecting the C-C′
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cyclic peptide at concentrations ranging between 10 and 500µM.
Experiments were carried out in HBS buffer (10mM HEPES,
150mMNaCl, 3mM EDTA, pH 7.4). The association phase (kon)
was followed for 270 s, whereas the dissociation phase (koff)
was followed for 300 s. The reference chip sensorgrams were
subtracted from sample sensorgrams. Experiments were carried
out in duplicates. Kinetic parameters were estimated assuming
a 1:1 Langmuir binding model and using version 4.1 Evaluation
Software (GE Healthcare).
Fluorescence binding analysis
rScl1.3FL protein, at a concentration of 30µM, was incubated
with increasing concentrations of C-C′ cyclic peptide (0–
300µM) at 25.0◦C, using an excitation wavelength of 298.0
nm and a fluorescence emission wavelength ranging from 300
to 400 nm. The acquisition parameters were set as follows:
excitation and emission slits at 5 nm; 120 nm/min scan rate;
1.00 nm data interval averaging time at 0.500 s, PMT voltage
at “high.” Fluorescence values were recorded at 333 nm, and
subtracted from the fluorescence intensity of the ligand-free
protein, generating−∆fluorescence. The−∆fluorescence values
were plotted against the peptide concentration (Williamson,
2013). Experiments were carried out in duplicates. A control
assay was carried out employing the buffer as titrant to
assess that the dilution effect was under 3%, not affecting
the results.
Complementation of GAS Strains with
Full-Length Scl1.3FL
For trans-complementation experiments, plasmid pSL502,
encoding full-length cell-associated Scl1.3FL protein, was
electroporated into MGAS315 WT and MGAS6183∆scl1
electrocompetent cells. The pJRS525 vector was electroporated
as a control. Transformants were selected on BHI agar
containing 100µg mL−1 spectinomycin, and plasmids
were re-sequenced. For MGAS10870∆scl1, which contains
a spectinomycin resistance cassette in place of the scl1.3 allele,
the spectinomycin resistance marker in pSL502 was replaced
with a kanamycin resistance, generating the plasmid pSL518 and
colonies were selected on BHI agar containing 150µg mL−1
kanamycin.
Determination of Scl1.3- and Scl2.3-Protein
Expression in Wild-Type and Complemented GAS
Strains
Western blot analysis
Expression of the Scl1.3 and Scl2.3 proteins was determined by
western immunoblotting of the bacterial cell wall and culture
supernatant protein fractions, as described before (Lukomski
et al., 2000, 2001). Briefly, bacterial cultures were grown to an
OD600 of 0.5 and cells were harvested by centrifugation. Culture
supernatant proteins were precipitated with trichloroacetic acid
(Sigma) to a final concentration of 10% (vol:vol). The cell wall
protein fraction was obtained after cell digestion with lysozyme
and mutanolysin in a high sucrose buffer. A total of 10 µg of
protein samples were separated by SDS-PAGE and transferred
to a nitrocellulose membrane. Detection of Scl1.3, Scl2.3, and
M3 proteins was performed using the same sample preparations
with rabbit polyclonal antibodies generated against the truncated
rScl1.3WT protein (anti-Scl1 1:15,000 dilution, reported in Flores
et al., 2015) and the rScl2.3V region (anti-rScl2.3V 1:2500;
generated by Proteintech Squeglia et al., 2014). Horseradish
peroxidase-conjugated goat anti-rabbit IgG (H+L) secondary
antibody (Bio-Rad), combined with PierceTM ECL western
blotting substrate (Thermo Scientific) was used for detection.
Images were acquired using a ChemiDoc Touch Imaging System
(Bio-Rad).
Flow cytometry analysis
Surface detection of Scl1.3 and Scl2.3 proteins was determined by
flow cytometry. Bacteria grown to anOD600 of 0.5 were harvested
by centrifugation, and washed with flow cytometry buffer (sterile
phosphate-buffered saline containing 10% Todd-Hewitt broth
supplemented with 0.2% yeast extract). Cells were incubated with
polyclonal antibodies against Scl1.3 and Scl2.3 described above at
a dilution of 1:100 for 30min on ice, then washed and incubated
with Allophycocyanin (APC)-conjugated donkey anti-rabbit IgG
(H+L) (Jackson ImmunoResearch) for 30 min on ice. Cells
were washed and fixed in 0.4% paraformaldehyde, and stored
at 4◦C until analysis. Before analysis, cells were washed twice
and resuspended in flow cytometry buffer. Cells were analyzed
using a BD LSRFortessa, and 50,000 events were collected
per sample. Data was analyzed using the FCS Express Flow 5
software.
Assessment of Biofilm Formation
Crystal Violet Staining Assay
Wild-type, mutant, and complemented strains were grown to
OD600 of 0.5 and seeded into 24-well culture plates coated with
ECM at 2µg per well, then incubated at 37◦C with 5% CO2
for 24 h. Wells were washed with PBS followed by the addition
of 0.5mL 1% crystal violet solution (Fisher Scientific) diluted
in PBS and incubation at room temperature for 30 min. Wells
were rinsed twice with PBS and stain was solubilized with 0.5
mL of 75% ethanol. Spectrophotometric readings were taken for
each sample at OD600. Statistical analysis is shown based on
three independent experiments, each containing three technical
replicates, using an unpaired t-test.
Confocal Laser Scanning Microscopy (CLSM)
To visualize GAS by CLSM, bacterial cells were transformed with
a GFP-encoding plasmid pSB027 (Cramer et al., 2003), as before
(Oliver-Kozup et al., 2011). Fifteen millimeter glass cover slips
were placed into 24-well tissue culture plate wells and coated
with 2µg of cFn or Lm per well. Bacterial cultures grown to
logarithmic-phase were added to the wells and allowed to form
biofilms for 24 h. Wells were rinsed with PBS and bacterial cells
were fixed with 3% paraformaldehyde at room temperature for
30min. Wells were washed again and coverslips were mounted
onto slides using ProLong Gold Antifade Mountant (Thermo
Scientific). Confocal images were acquired using a 63 × /1.40
Plan-Apochromat objective and a Zeiss LSM 510 laser scanning
confocal microscope.
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In vitro and In vivo GAS Infection Models
GAS Infection of In vitro Cultured Human Skin
Equivalents
Wounded full-thickness skin equivalents, EpiDerm-FT (MatTek,
Boston, MA) were used. The tissues are discs 8mm in diameter,
which are provided in transwells. A 3-mm wound is generated
by performing a punch biopsy to remove the keratinocyte
layer. Immediately upon arrival, tissues were equilibrated in
antibiotic-free manufacturer’s medium overnight at 37◦C in
atmosphere with 5% CO2. Wounds were infected with 10µL
of GFP-expressing log-phase group A streptococcal inocula and
incubated in a humid environment at 37◦C with 5% CO2 in
daily-fresh media; a total of 4 experiments were performed and
variables included the inoculum size of 3 × 106 − 1.8 × 107
CFU and collection time points between 1 and 5 days. Tissues
designated for histopathological evaluation were fixed in 10%
formalin, whereas tissues for two-photon fluorescence (TPF)
microscopy imaging were fixed in 4% paraformaldehyde for
several hours and then transferred to petri dishes containing
PBS. For visualization of glycocalyx produced by GAS strains,
tissues were permeabilized with 0.1% Triton X-100 in 1 × PBS
and blocked with 0.05% Triton X-100 in 1 × PBS with 1%
BSA before staining with concanavalin A- tetramethylrhodamine
(Molecular Probes). Tissues were then rinsed and stored in PBS
at 4◦C until TPF imaging was performed. For TPF analysis,
an Olympus 60 × /1.2NA water dipping objective was used.
Fixed tissues were imaged by two-photon microscopy with the
Ti:sapphire laser (Mira, Coherent) intensity at 60 mW and input
wavelength of 850 nm. Laser scanning images were collected at
0.5−1µm incremental depths using ScanImage (Janelia Farms,
HHMI). Images were saved in a single TIFF file with 16 bit depth.
Deconvolution of the images was performed using AutoQuant
× 3 and 3D models of z-stacks were generated using Imaris
software.
Mouse Model of Soft Tissue Infection
Animal experiments were conducted in compliance with the
regulations and standards under the Animal Welfare Act, the
Public Health Service Policy on Humane Care and Use of
Laboratory Animals, and the Guide for the Care and Use
of Laboratory Animals. The protocol was approved by the
West Virginia University Institutional Animal Care and Use
Committee (IACUC).
Subcutaneous infections of mice were carried out as described
previously (Lukomski et al., 1999). Briefly, 5-week-old male,
immunocompetent, hairless mice (strain Crl:SKH1-hrBR) were
used (Charles River, Wilmington, MA). Groups of 10–15 mice
anesthetized with isoflurane were infected subcutaneously at
the right flank with ∼109 GAS CFU of WT or scl1-mutant
strains, and mice were observed for 14 days. The weight and
abscess dimensions (length [L] and width [W]) of each mouse
were recorded daily during the first week and every other
day thereafter. To analyze differences between mice infected
with WT and scl1-mutant GAS, the area of each abscess was
calculated with the equation for the area (A) of an spherical
ellipsoid: A = pi(L/2) × (W/2); statistical differences were
calculated using the student’s t-test. At the conclusion of the
experiments, mice were anesthetized and sacrificed by cervical
dislocation.
RESULTS
M3-Type GAS Contain Unique Insertion of
IS1548 Element and Nonsense Mutation
within the scl1.3 Locus
Since the resurgence of invasive GAS infections in the 1980s
and an advent of molecular epidemiology fostered by large-
scale sequencing, significant efforts have been made to define the
molecular basis for the invasive phenotype of M3-type strains.
In parallel to these advances, we identified two unique genomic
traits in the scl1.3 locus, encoding streptococcal collagen-like
protein 1: (i) the presence of an insertional sequence element,
IS1548, in the promoter region and (ii) the presence of a nonsense
mutation within the coding sequence of scl1.3 allele that was
absent in other M-types.
Studies employing mga-inactivated mutants have indicated
that Scl1 expression was positively regulated by the GAS-global
transcriptional regulator, Mga (Rasmussen et al., 2000; Lukomski
et al., 2001). Two putative Mga binding sites were identified
upstream of the scl1 coding sequence in theM1-type strain SF370
and experiments demonstrated that the Mga binding site distal
to scl1 was responsible for transcription activation (Almengor
and McIver, 2004). Identical Mga binding sites I and II were
also identified upstream of scl1.3 in the sequencedM3-type strain
MGAS315 with IS1548 element inserted 38 bp upstream of the
distal Mga I-binding site (Figure 1A). To determine if the IS1548
insertion was specific to M3 strains, we BLAST-searched this
element in 45 completed GAS genomes representing 21 different
M-types. We observed the presence of IS1548 in all strains
searched with varying locations and occurrences from 1 to 12 per
genome (Figure 1B). However, the IS1548 insertion upstream
of the scl1.3 allele was only found in the sequenced genomes
of M3-type strains MGAS315, SSI-1, and M3-b. Interestingly, a
complete IS1548 element was not present upstream of scl1.3 in
the recently reported genome of the M3 strain STAB902, which
represents a non-invasive isolate (Soriano et al., 2014); instead,
a 34-bp remnant of IS1548, including the inverted repeat and
additional 14 bp, was found. Based on this bioinformatics data,
we examined the presence of the IS1548 element upstream of scl1
by PCR in a panel of 40 M3-type strains, using primers located
in the IS1548 and scl1.3 sequences (IS1548F and Scl1R, Table S1).
All M3-type strains examined were positive for the IS1548-scl1.3
amplicon, while M1, M41, and M28-type controls were negative
(Figure 1C), demonstrating a broad and conserved presence of
the IS1548 insertion in this location among M3-type GAS.
The nonsense mutation in the 11th Gly-X-Y repeat in the
Scl1.3-CL collagenous region (Figure 1A, red box), presumably
results in a truncated secreted variant, which consists of the
Scl1-V variable region and 10 Gly-X-Y repeats but lacks the
cell wall anchor. This polymorphism was originally identified in
five M3-type invasive GAS strains but was absent in 45 other
strains analyzed, representing 20 different M-types (Lukomski
et al., 2000). It was later shown in 98.7% of 479 sequenced
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FIGURE 1 | M3-type GAS strains harbor unique polymorphisms in the scl1.3 locus. (A) Schematic representation and nucleotide sequence are based on the
scl1.3 locus in the M3-type strain MGAS315 genome. The scl1.3 promoter region contains two putative Mga binding sites, Pscl1-I with Mga I and Pscl1-II with Mga II.
IS1548 is inserted 38 bp upstream of the preferred *Pscl1-I/Mga I promoter, which was shown to be necessary for scl1 transcription. Transcriptional start site (solid
dot), −10 and −35 boxes are shown upstream of scl1.3 coding sequence. Scl1 regions are designated as follows: SS, signal sequence; V, variable region; CL,
collagen-like region; L, linker region; WM, wall-membrane region; LPATG, cell-wall anchor. The null mutation in the 11th Gly-X-Y repeat of the CL region is depicted by
the red box, presumably resulting in a truncated secreted Scl1.3 protein. Relative location of primers, IS1548F and Scl1R, used to generate amplicons in (C) are
shown. (B) IS1548 insertion upstream of scl1.3 is unique to M3 genomes. BLAST search in the NCBI nucleotide (nr/nt) database using IS1548 (1317 bp) sequence as
query identified insertions in 45 GAS genomes representing 21 different M-types. Only genomes of M3-type strains harbored IS1548 element upstream of the scl1
allele (bold text). (C) IS1548 insertion upstream of scl1.3 is conserved among M3 strains. Genomic DNA was isolated from a collection of 40 M3-type strains and
analyzed by PCR for the presence of IS1548 upstream of scl1 using primers IS1548F and Scl1R (located in conserved scl1 signal sequence). Additional M1-, M41-,
and M28-type control strains, and a no template control (NTC) are included. Expected amplicon size, 963 bp; M, 1 kb Plus DNA Ladder. MGAS designation applies to
all strain numbers shown above gel wells, with the exception of strain AM3.
invasive M3-type isolates (Flores et al., 2015). We performed
targeted PCR amplification of scl1.3 from 46 additional M3-type
strains and observed identical amplicon sizes in all of them
(Figure S1A). Sequencing showed that all tested strains harbored
an identical scl1.3 allele, containing 25 Gly-X-Y repeats in the
collagenous domain with the null mutation in the 11th repeat
(Data Sheet 1). A complete lack of genetic variation within
scl1.3 is surprising and differs from the length variation that
is commonly observed among scl alleles from other M-types
(Lukomski et al., 2000; Rasmussen et al., 2000; Whatmore, 2001).
These results demonstrate that the IS1548 insertion and null
mutation we identified in the scl1.3 locus are unique to and
conserved among M3-type GAS. Based on these results, we
hypothesized M3 strains produce a truncated, but potentially
biologically active Scl1.3 variant, which is secreted instead of
being cell-attached.
scl1.3 Expression Is Diminished in M3-Type
GAS
Original reports showed scl1 transcripts in northern blots, as
well as full-length Scl1 proteins (both cell-associated and cell-free
fractions) in western blots for strains of emm types 1, 28, 52,
and 41 (Lukomski et al., 2000, 2001; Rasmussen et al., 2000;
Caswell et al., 2007). To analyze the expression of the truncated
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Scl1.3 protein in M3-type GAS, western blot analysis was
performed on cell-wall (CW samples) and culture-supernatant
(Sup samples) protein fractions of several M3-type strains grown
to exponential phase (Figure 2A). The expected truncated Scl1.3
protein was not detected by anti-Scl1 antibodies, whereas the
rScl1.3V positive control, corresponding to the V region of Scl1.3
variant, produced the expected immunoreactive band of ∼8.3
kDa. In an additional control experiment, the same panel of
FIGURE 2 | Assessment of Scl1.3 expression. (A) Assessment of Scl1.3 production by M3-type GAS. Cell wall (CW) and culture supernatant (Sup) protein
fractions prepared from exponential phase cultures of several M3-type strains were analyzed by western immunoblotting, using anti-Scl1 rabbit polyclonal antibody.
Recombinant protein rScl1.3V, corresponding to the variable region of Scl1.3, was used as a positive control. Expected molecular masses: Scl1.3, 11.4 kDa; rScl1.3V,
8.3 kDa. M, PageRulerTM Plus Prestained Protein Ladder. (B) Detection of Scl1.3 on the surface of M3-type GAS. Flow cytometry analysis of several M3-type strains
is shown using anti-Scl1 antibody described in part (A) (color-shaded histograms) or a secondary only control (2◦ sample, black outlined histogram). Median
fluorescence intensities (MFI) are shown in parentheses for each strain. (C) Assessment of scl1 transcription. Fold-change of scl1 transcript levels are shown
compared to scl1.3 transcription in M3-type strain MGAS315. qRT-PCR was performed on RNA obtained from exponential phase cultures. Results are shown from
three independent experiments, each performed in triplicate wells. Standard errors and statistical analysis were computed from averaged ∆Ct values for each
biological replicate prior to normalization against the endogenous reference gene tufA; *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 (student’s t-test). (D) Assessment of mga
and emm transcription. Relative expression levels of mga and emm genes were compared between MGAS315 and four additional M3 strains or the M1 strain
MGAS5005. Results are shown from three independent experiments, each performed in triplicate wells. Standard errors and statistical analysis were computed from
averaged ∆Ct values for each biological replicate prior to normalization against the endogenous reference gene tufA; **P ≤ 0.01. (E) Assessment of M3-protein
production by M3-type GAS. The same cell wall (CW) and culture supernatant (Sup) protein samples prepared from exponential phase cultures of M3-type strains
(used in A) were analyzed by western immunoblotting, using anti-M3 protein rabbit polyclonal antibody. Expected molecular mass: 65 kDa. M, PageRulerTM Plus
Prestained Protein Ladder.
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M3 strains was tested for Scl1.3 on the cell surface using flow
cytometry (Figure 2B). No shift in median fluorescence intensity
was observed in M3 strains incubated with anti-Scl1 antibody
compared to a secondary-only antibody control, indicating a lack
of Scl1 on the cell surface among M3 strains.
Given the unique IS1548-scl1.3 location and the lack
of truncated Scl1.3 products in culture supernatants, we
investigated scl1.3 expression by qRT-PCR. Total RNA was
isolated from exponential phase cultures of 5 M3-type strains,
as well as from previously characterized control strains of emm
types 1, 28, and 41 (Lukomski et al., 2000, 2001; Rasmussen et al.,
2000; Caswell et al., 2007). Expression of scl1 from each strain
was compared to scl1.3 transcription in M3 strain MGAS315
(Figure 2C). Each non-M3-type strain tested had significantly
higher transcription level of respective scl1 allele compared to
MGAS315. The M1 strain had the most increased expression
by 21-fold, while M28 and M41 strains exhibited 6- and 8-
fold higher scl1 expression, respectively. Interestingly, the scl1.3
transcripts examined in four additional M3-type MGAS strains
158, 335, 1313, and 10870 were significantly reduced as compared
to MGAS315, with a range of 25- to 45-fold decrease. Overall, we
observed that M3-type GAS harboring the IS element upstream
of scl1.3 have drastically decreased scl1.3 transcript levels and lack
the Scl1 protein product, as assessed by western blot and flow
cytometry.
Since scl1 is regulated by the transcriptional activator Mga,
we investigated whether the decreased scl1.3 transcripts in M3
strains were due to lack of mga gene expression in these
strains. In parallel, we assessed transcript levels of the emm gene
encoding the M surface protein, a key virulence factor regulated
by Mga. For comparison, we included the M1 strain, which
had significantly increased scl1 expression compared to the M3
strains. With the exception of MGAS335, which had significantly
downregulatedmga and emm expression, we found no significant
differences in either mga or emm gene expression between
MGAS315 and the other M3 strains or M1 strain (Figure 2D).
Furthermore, M3 protein was highly expressed, as it was found in
both cell wall and supernatant fractions, except for the MGAS335
strain, consistent with transcription data (Figure 2E). These
results demonstrate that the striking downregulation of scl1.3
in M3-type GAS is not due to decreased mga expression or
non-functional Mga protein, as emm is normally expressed in
these strains.
scl2.3 Is Expressed in M3-Type GAS
Scl2 shares a similar structure with Scl1 but its biological function
is poorly understood. One study demonstrated in a different M-
type background that isogenic mutant devoid of Scl2.55 variant
had lower adhesion to human skin fibroblasts (Rasmussen and
Björck, 2001); however, the Scl2.3 variant present in M3-type
GAS has not been investigated for expression and ECM binding.
Therefore, we next assessed scl2.3/Scl2.3 expression inM3 strains.
PCR amplification and sequencing showed that the majority of
M3 strains contained in-frame scl2.3 allele (Figure S1B, Table S2).
Western blot analysis of cell wall (CW samples) and
supernatant (Sup) protein fractions found Scl2.3 protein was
expressed by M3 strains MGAS315, 10870, 158, 9517, and 1313,
whereas samples obtained from strainMGAS335, which contains
an out-of-frame scl2.3 allele, generated no immunoreactive
band; rScl2.3V control produced the expected 10.1-kDa band
(Figure 3A). Mass spectrometry confirmed the identity of the
presumed immunoreactive Scl2.3-protein band from MGAS315
(Table S3). Consistently, Scl2.3 was detected on the surface of
all five M3 strains containing in-frame scl2.3 alleles by flow
cytometry, with a positive shift in median fluorescence intensity
ranging in 67- to 131-fold change, as compared to the secondary-
only antibody control (Figure 3B). We next compared the scl2-
transcription level inM3 strainMGAS315 with scl2-transcription
levels in M1-, M28-, and M41-type strains. In striking contrast
to the pattern of scl1.3 transcription, scl2 transcripts were
significantly decreased in the M1-type strain by 13-fold, as well
as in the M28 (6-fold) and M41 (3-fold) strains (Figure 3C).
Additionally, there was no significant difference between scl2
expression in MGAS315 and the M3 strains MGAS158, 335,
1313, and 10870 (Table S4). These results confirm that the M3
scl2.3 allele is transcribed at high levels, resulting in considerable
expression of the Scl2.3 protein. These results suggested that Scl2
has an important biological function inM3 strains and warranted
subsequent experiments assessing Scl2.3 function.
GAS Infection Disseminates through
Human Tissue and Inhibits Wound Healing
A wounded human skin equivalent, devoid of an inflammatory
component, was utilized as a “mechanistic model” of GAS tissue
colonization. The epidermal wound of each skin equivalent was
infected with GFP-expressing M3-type invasive strain MGAS315
or M41-type non-invasive strain MGAS6183, and analyzed
after 1–5 days by standard histopathology (H&E and Gram’s
stain) and using TPF microscopy. H&E of uninfected tissue
controls harvested at day 0 showed the absence of a keratinocyte
layer where the punch biopsy was performed (Figure 4A).
Complete healing of the wound was observed after 5 days,
with a newly-generated intact keratinocyte layer covering the
punch biopsy site (Figure 4B). In contrast, tissue infected with
either GAS strain exhibited delayed wound closure as late
as day 5 post-infection (Figures 4E,H). H&E staining of skin
equivalents infected with either M3 or M41 after 24 h revealed
bacterial colonization of the exposed dermal surface, as well
as bacterial invasion into puncture-associated defects extending
deep into the dermal layer, largely located at the wound edges
(Figures 4D,G). Notably, extensive bacterial growth and spread
was largely confined to tissue crevices in the dermis, whereas
the presence of large bacterial colonies directly below the wound
bed was rarely seen on microscopic examination. By day 5 of
infection, bacterial invasion via these dermal defects extended
to the bottom of the dermis for both strains, presenting both
vertical and lateral spread of bacteria (Figures 4E,H). Gram
stain of infected tissues showed the formation of superficial
colonies near dermal surfaces, as well as biofilm formation on
the surface of exposed dermis (Figures 4J–M). Additionally,
epidermal tissue neighboring the wound bed exhibited ∼60%
decreased thickness of the viable keratinocyte layer in tissues
infected with MGAS315 and MGAS6183 by day 5, relative
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FIGURE 3 | Characterization of the scl2.3 locus in M3-type GAS. (A) Assessment of Scl2.3 production by M3-type GAS. The same cell wall (CW) and culture
supernatant (Sup) protein samples prepared from exponential phase cultures of several M3-type strains (used in Figures 2A,E) were analyzed by western
immunoblotting, using anti-rScl2.3V rabbit polyclonal antibody. Recombinant protein rScl2.3V, corresponding to the variable region of Scl2.3 protein, was used as a
positive control. Expected molecular masses based on MGAS315: Scl2.3, 52.5 kDa; rScl2.3V, 10.1 kDa. Aberrant migration of detected Scl2.3 variants is
characteristic of Scl proteins. M, PageRulerTM Plus Prestained Protein Ladder. (B) Detection of Scl2.3 on the surface of M3-type GAS. Flow cytometry analysis of
several M3-type strains is shown using anti-rScl2.3V rabbit polyclonal antibody (color-shaded histograms) or a secondary-only control (2◦ sample, black outlined
histogram). Median fluorescence intensities (MFI) are shown in parentheses for each strain. (C) Assessment of scl2 transcription. Fold-change of scl2 transcription
levels are shown compared to scl2.3 transcription in M3-type MGAS315. qRT-PCR was performed on reverse-transcribed RNA obtained from exponential phase
cultures. Results are shown from three independent experiments, each performed in triplicate wells. Standard errors and statistical analysis were computed from
averaged ∆Ct values for each biological replicate prior to normalization against the endogenous reference gene tufA; *P ≤ 0.05, **P ≤ 0.01 (student’s t-test).
to uninfected tissues (Figures 4C,F,I). This suggests bacterial
infection of the wound affects epidermal cells distant from the
site of infection in this model.
TPF analysis was the performed on whole infected skin
equivalents on day 5 post-infection in order to assess bacterial
spread directly below the wound bed. This method allowed
us to visualize bacterial structures within tissue that were
not apparent in H&E or Gram-stained sections. Tissue
microcolonies were observed in samples infected with M41
GAS (Figure 4N), whereas M3 cells had a scattered appearance
(Figure 4P). TRITC-concanavalin A (TRITC-conA) was utilized
to visualize glycocalyx associated with bacteria. TRITC-conA
stain colocalized with bacterial microcolonies formed by the
M41 GAS (Figure 4O, Figure S3), indicating microcolonies
were encased in a glycocalyx, much like a classic biofilm. In
contrast, TRITC-conA stain was associated with scattered M3-
GAS chains located at the bottom cell layer inMGAS315-infected
skin equivalents (Figure 4Q). These results indicate that M41
GAS, but not the M3 GAS, forms microcolonies in the tissue
during a human skin infection that are encased in a glycocalyx,
consistent with the observation thatM41, but notM3, GAS forms
robust biofilm in vitro on ECM coatings. In addition, M3 GAS
disseminates in a form of scattered chains or single cells through
the tissue.
M3-Type GAS Strains form Poor Biofilms
on Extracellular Matrix Coatings
It was previously reported that M3-type strains have no
substantial biofilm formation in vitro on an inanimate surface
(Oliver-Kozup et al., 2011). Here, we tested biofilm formation
on cellular fibronectin (cFn) and laminin (Lm) coatings by a
panel of representative M3 strains isolated from invasive cases
of GAS disease, as compared to the non-invasive biofilm-capable
M41-type model strain MGAS6183. As expected, wells coated
with either cFn or Lm supported robust biofilm formation
by the M41 strain, whereas significantly less bacterial biomass
was measured for all M3-type GAS on both ECM coatings
(Figure 5A). There was also no correlation between Scl2
expression and biofilm formation. We hypothesized that M3-
type GAS, devoid of Scl1 adhesin, have decreased binding to
cFn and Lm ECM components, thus, preventing the formation
of tissue microcolonies, and that restoration of full-length Scl1.3
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FIGURE 4 | In vitro skin equivalent model of GAS infection. (A–I) H&E stained sections of uninfected (A–C) or infected (D–I) wounded skin equivalents at 40x
magnification; scale bar: 1000 µm. Uninfected wound at day 0 (A) shows a lack of the epidermal layer where biopsy punch was performed, which healed by day 5
(B). At day 1, infection of wounded skin equivalents with M3 and M41 GAS revealed superficial colonization of the wound bed, as well as invasion into the defects
formed at the wound edge (D,G, arrows). By day 5, bacteria had disseminated throughout tissue laterally and vertically (arrows), reaching the bottom of the dermis
layer (E,H). (C,F,I) H&E stained sections of the keratinocyte layer of intact skin surrounding the biopsy punch; scale bar: 100 µm. The thickness of the viable
(Continued)
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FIGURE 4 | Continued
keratinocyte layer outside the wound (C, double arrow) was significantly reduced in tissues infected with M3 (F) and M41 (I) by day 5. (J,L) Gram stained sections of
wounded tissue, corresponding to boxed areas in (D,H), show tissue microcolonies (arrows) and superficial bacterial colonization (arrowheads). (J, scale bar: 400 µm;
L, scale bar: 200 µm). (K,M) 1000x magnification micrographs of surface biofilms shown in (J,L) (scale bar: 10 µm). (N–Q) Two-photon fluorescence microscopy
analysis of infected skin equivalents. Vertical dissemination through the wound bed and glycocalyx formation by the GFP-expressing M41- (N,O) and M3-type (P,Q)
GAS at day 5. 3D projections of z-stacks are shown from the top view of the z-stack (top panels) or the side view (bottom panels). Multi-channel images show GFP
fluorescence of GAS cells (N,P) and TRITC-conA stain of glycocalyx (O,Q). All images were acquired at 600x magnification.
(Scl1.3FL) on the GAS cell surface will confer binding to host
ECM, as well as biofilm capacity in vivo (Figure 5B).
Full-Length Recombinant Scl1.3 Binds
Cellular Fibronectin and Laminin
To test this hypothesis, we: (i) constructed Scl1.3- and Scl2.3-
derived recombinant proteins, (ii) characterized their structural
organization, and (iii) assessed their ECM-binding capacities.
First, rScl1.3FL and rScl2.3 proteins were assessed for purity
and integrity by SDS-PAGE (Figure 6A). The expected 20.6-kDa
rScl1.3FLmigrated at∼34 kDa, which is consistent with previous
reports of aberrant migration of rScl proteins (Lukomski et al.,
2000, 2001), whereas the rScl2.3 protein migrated according
to the expected molecular mass of 16.2 kDa; both proteins
were verified by mass spectrometry (Table S3). Rotary shadowed
rScl1.3FL and rScl2.3 constructs, exhibited the characteristic
lollipop-like structural organization (Figure S2), as observed for
previously characterized rScl proteins (Xu et al., 2002; Han et al.,
2006b). Interestingly, rScl1.3FL formed aggregates that were
mediated by the intermolecular interactions between the globular
domains; such interactions, however, were not observed between
rScl2.3molecules. The appearance of Scl1-Scl1 aggregates implies
an attractive hypothesis that V-to-V-region interactions between
the Scl1 molecules, but not between the Scl2 molecules, on
the surface of neighboring GAS chains may support biofilm
structure, as proposed in our model (Figure 5B).
It has been established that Scl1 proteins selectively bind
cellular, but not plasma, fibronectin and laminin (Caswell
et al., 2010), and that selective cFn binding is achieved by
a unique binding mechanism involving the C-C′ loop of the
extra domain A in cFn (EDA-cFn) (Oliver-Kozup et al., 2013).
Here, we pre-incubated cFn with increasing concentrations of
EDA-blocking IST-9 mAb (0.1, 1.0µg), then added to wells
containing immobilized rScl proteins and allowed for binding.
We observed significant dose-dependent inhibition of cFn
binding to rScl1.3FL, with a 36% inhibition at 0.1µg and a
60% inhibition at 1.0µg of IST-9 (Figure 6B). In addition, the
rScl2.3 protein did not bind cFn, which is consistent with our
previous data employing several different rScl2 proteins (Caswell
et al., 2010). Surface plasmon resonance (SPR) measurements
of binding affinity between rScl1.3FL and EDA-derived C-C′
cyclic peptide provided a dissociation constant of KD = 63.3
µM (Figure 6C). To corroborate the rScl1.3FL-EDA binding
affinity, an in-solution fluorescence binding assay was performed,
in which the variation in tryptophan fluorescence of rScl1.3FL
was recorded as a measure of positive binding to the C-C′
cyclic peptide. Tryptophan fluorescence emission at 333 nm
showed a dose-response quenching upon addition of the C-C′
cyclic peptide and −1 fluorescence intensity was plotted against
peptide concentration (Figure 6D). Data were fitted with a 1:1
model of interaction, providing a KD = 44.54 ± 9 µM, in
agreement with SPR data (Russo et al., 2015).
We next assessed binding of rScl1.3FL and rScl2.3 proteins to
laminin (Lm) by ELISA.We determined rScl1.3FL had significant
Lm binding, whereas rScl2.3 had not (Figure 6E), consistent
with previous findings that Scl1-derived recombinant proteins,
but not the Scl2-derived, bind ECM proteins (Caswell et al.,
2010). Collectively, these results demonstrate specific binding of
Scl1.3FL to the EDA domain of cFn and to Lm and its capacity of
being surface adhesin.
Homologous Complementation of M3
Strains with Full-Length Surface-Exposed
Scl1.3 Adhesin Confers Biofilm Formation
on ECM
To assess the effect of cell-surface Scl1.3FL expression on the
capacity to form biofilm, an in-trans complementation of two
representative invasive M3 strains was performed, MGAS315
wild-type (WT) strain, naturally lacking Scl1.3 expression, and
a previously generated scl1-inactivated mutant of MGAS10870
(10870∆scl1), with plasmids pSL502 (SpR) and pSL518 (KmR),
respectively, both encoding the full-length Scl1.3FL protein.
As a control, MGAS315 was complemented with a shuttle
vector pJRS525. The cell wall-associated expression of Scl1.3FL
in complemented M3-type GAS was first tested by western
blot analysis of the cell wall protein fractions and on the
GAS-cell surface by flow cytometry. An expected ∼35-kDa
immunoreactive band in complemented strains was observed,
which was absent in the parent strains (Figure 7A). Mass
spectrometry analysis of the corresponding bands extracted from
the gel confirmed they represented the Scl1.3FL protein, with
five unique peptides identified with 17% sequence coverage for
complemented MGAS315 and four unique peptides identified
with 11% sequence coverage for complemented MGAS10870
(Table S3). A 6.8-fold increase in median fluorescence intensity
of Scl1.3FL-complemented MGAS315 cells was measured by
flow cytometry, as compared to the vector-complemented and
WT control strains (Figure 7B). The Scl1.3FL-complemented
10870∆scl1 exhibited a 2.2-fold increase in median fluorescence
intensity, as compared to the mutant control (Figure 7B). These
results indicate the Scl1.3FL is indeed expressed and surface-
exposed in the complemented M3-type strains.
Biofilm formation by the complemented and parent strains
was then assessed after 24 h following crystal violet staining
and using confocal laser scanning microscopy (CLSM). Scl1.3FL-
expressing MGAS315 showed significantly increased biomass
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FIGURE 5 | In vitro biofilm formation and hypothetical model of
microcolony formation by invasive M3-type GAS. (A) Limited in vitro
biofilm formation by invasive M3 strains on coatings with cellular fibronectin
and laminin. Invasive M3-type strains were compared to a non-invasive
biofilm-capable M41-type strain MGAS 6183. Crystal violet staining was used
to assess biomass formed after 24 h of growth in wells coated with cellular
fibronectin (cFn) and laminin (Lm); results represent averaged values from at
(Continued)
FIGURE 5 | Continued
least 3 independent experiments performed in triplicate wells. **P ≤ 0.01
(student’s t-test). (B) Hypothesis model. Top: Infection of wounded skin with
wild-type M3-type GAS. Inherent lack of surface-expressed Scl1.3 causes
decreased binding to cFn and Lm expressed in wounded tissue, and reduces
biofilm and tissue microcolony formation by M3-type bacteria (red circles).
Bottom: In-trans complementation of M3-type GAS with full-length
cell-associated Scl1.3, Scl1.3FL, restores binding to cFn and Lm in tissue,
which confers biofilm and tissue microcolony formation during infection.
on both cFn and Lm coatings compared to the WT parent
organism, as well as vector-complemented control; 3.6 or
2.5- and 2.5 or 2.1-fold OD600 increases on cFn and Lm,
respectively, were measured compared to MGAS315 WT or
to vector-complemented MGAS315 (Figure 7C). Significantly
thicker biofilm formed by Scl1.3FL-complemented MGAS315
was imaged by CLSM. We observed on average a 2.8-fold (P
= 0.0002) and 2.6-fold (P = 0.0002) increased biofilm thickness
on cFn and Lm, respectively, compared to MGAS315 WT, and a
2.0-fold (P = 0.0036) and 4.8-fold (P = 2.1 × 10−5) increased
biofilm thickness on cFn and Lm, respectively, compared to
vector-complemented MGAS315 (Figures 7D,E, representative
images). Similar results were obtained for the complemented
10870∆scl1 mutant, which had 1.7-fold increase in biomass
staining on both cFn and Lm compared to the MGAS10870 WT
strain, and 2.2- and 2.6-fold increase in biomass staining on cFn
and Lm, respectively, compared to the 10870∆scl1mutant strain
(Figure 7C). CLSM data, however, could not be rendered for
MGAS10870 strains due to poor GFP expression for unknown
reasons. Altogether, it was demonstrated that null mutation in
the scl1 gene, which ablates surface Scl1.3 protein and is unique
toM3-type GAS, is responsible for the decreased biofilm capacity
since restoration of the full-length surface-exposed Scl1.3 adhesin
significantly fosters stable biofilm formation.
Heterologous Complementation of M41
∆scl1 Mutant Strain with Full-Length
Surface-Exposed Scl1.3 Restores Biofilm
Formation on ECM
In a previous study we showed that scl1.41-inactivation in a
non-invasive biofilm-rich M41 strain MGAS6183 resulted in
significantly decreased biofilm capacity, which was restored
to wild-type level by complementation with surface Scl1.41
(Oliver-Kozup et al., 2013). Notably, this M41 strain expresses
at least one additional major Fn-binding protein, protein F2
(Caswell et al., 2007), which binds both plasma and cellular
fibronectin by a mechanism different from Scl1 (Sela et al.,
1993). Here, we hypothesized that expression of rScl1.3FL in the
heterologous M41 GAS will confer biofilm formation. Western
immunoblotting of the cell wall protein fractions detected the
∼35-kDa immunoreactive band, corresponding to full-length
Scl1.3, associated with complemented cells, while the M41∆scl1
mutant and WT cells were signal-negative (Figure 8A). Mass
spectrometry of the corresponding band extracted from the gel
confirmed Scl1.3FL expression, with 3 unique peptides identified,
covering 13% of the amino acid sequence (Table S3). In addition,
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FIGURE 6 | Construction and binding characterization of recombinant
full-length Scl1.3FL and Scl2.3 proteins. (A) Affinity purified rScl1.3FL and
rScl2.3 proteins were analyzed by 4–20% gradient SDS-PAGE; expected
molecular masses: rScl1.3FL, 20.6 kDa and rScl2.3, 16.2 kDa. (B–D) Binding
of rScl1.3FL to extra domain A (EDA) of cellular fibronectin. (B) IST-9 antibody
inhibition identifies rScl1.3FL binding to the C-C′ loop of EDA-cFN. Inhibition of
rScl1.3FL binding to EDA-cFn was tested by ELISA following pre-incubation of
cFn with blocking IST-9 mAb specific to the C-C′ loop. Significance of
inhibition by 0.1 and 1.0µg of IST-9 mAb was determined by student’s t-test
as compared to the untreated cFn. A lack of significant cFn binding by rScl2.3
was evident, as compared to rScl1.3FL-cFn binding; student’s t-test. (C)
rScl1.3FL binding to a cyclic peptide mimicking the C-C′ loop of EDA using
surface plasmon resonance. Overlay of sensorgrams for the interaction
between immobilized rScl1.3FL and EDA-derived C-C′ cyclic peptide is
shown. The experimental curves corresponding to different concentrations of
peptide (10–500µM) were fitted according to a single binding model with 1:1
stoichiometry. (D) rScl1.3FL binding to a C-C′ cyclic peptide using tryptophan
fluorescence assay. Tryptophan fluorescence quenching analysis shows the
dose-response curve of the fluorescence values of rScl1.3FL at 333 nm
plotted against the concentration values of C-C′ cyclic peptide. (E) Laminin
binding to rScl1.3FL and rScl2.3 by ELISA. Recombinant rScl proteins were
immobilized onto Strep-Tactin-coated wells and incubated with laminin. Bound
laminin was detected with specific primary pAbs and HRP-conjugated
secondary Abs. Laminin binding was compared between rScl1.3FL and
rSc2.3 and evaluated statistically using student’s t-test. Results for (B,E)
represent averaged values from at least 3 independent experiments performed
in triplicate wells. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001.
we showed the expression of the larger Scl1.41 variant in the cell
wall of M41 WT, but not in the ∆scl1 mutant, by re-probing a
portion of the blot with anti-rScl1.41 antibody, using rScl1.41
protein as a positive control.
Similarly to complementation with homologous Scl1.41
protein, the heterologous complementation of the M41∆scl1
mutant with Scl1.3FL also restored biofilm to M41 WT
levels on cFn and Lm (Figures 8B–D). Crystal violet staining
showed increased bacterial biomass (Figure 8B) and confocal
microscopy revealed significantly thicker biofilms, on average 3-
fold increased, as compared to the parental M41∆scl1 mutant
strain on both cFn (Figure 8C) and Lm (Figure 8D) coatings
(cFn, P = 0.0105; Lm, P = 0.0011).
Expression of Scl1 Adhesin Attenuates
GAS during Subcutaneous Infection
We have previously shown that an M3 strain harboring a carrier
scl1.3 allele, producing a shorter cell-attached Scl1.3 variant,
had an attenuated phenotype in a murine model of necrotizing
fasciitis (Flores et al., 2015). Here, we tested our hypothesis that
Scl1 adhesin in biofilm-rich M28 andM41 background promotes
stable colonization and localized infection, using a murine skin
infection model. Hairless, immunocompetent SKH1 mice were
subcutaneously infected with ∼109 GAS CFU of the M28 and
M41 wild-type (WT) or their isogenic scl1-inactivated mutant
(scl1) strains (Han et al., 2006a; Caswell et al., 2007), and mice
were assessed for changes in gross pathology of the skin.
Skin lesions caused by both the WT and scl1 strains were
observed as early as 48 h post-infection, and the lesions began
to regress after day 7 with complete resolution of the lesion by
the completion of the experiment. The areas of the skin lesions
calculated for mice infected with the scl1 mutant strains were
significantly larger than those of WT-infected mice (Figure 9A;
96 h time-point is shown); images of lesions of representative
mice demonstrate differences in lesion severity between WT-
and scl1-GAS infected mice for both the M28- and M41-infected
groups (Figure 9B). Thus, the in vivo data, using GAS strains
expressing surface Scl1 proteins and producing rich biofilms,
support our hypothesis that decreased adhesion and biofilm
formation, due to the absence of Scl1.3 on the surface of M3
strains, bears an inverse correlation to the invasive potential of
the infecting GAS strain.
DISCUSSION
Since the resurgence of invasive GAS disease in the 1980’s,
and emergence of invasive M3-type isolates, significant efforts
have been made to determine the molecular basis for the
invasive phenotype ofM3-type strains. Numerous whole-genome
sequencing projects have identified specific genomic features of
M3 strains that were correlated with their potential to cause
invasive infections. In this study, we show that Scl1-negative M3-
type GAS have reduced adhesion and biofilm formation within
host tissue, and therefore are predisposed to invasive spread over
superficial infection (Figure 10).
Unique Topography and Expression
Patterns of scl Loci
First, the insertion of IS1548 element in the promoter region
of scl1 exclusively found in the M3-type strains is an intriguing
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FIGURE 7 | Homologous complementation of M3-type GAS with full-length surface-expressed Scl1.3 protein confers biofilm formation. (A) Western
blot detection of full-length Scl1.3 in cell wall fractions of MGAS315 and MGAS10870∆scl1 complemented in-trans with the scl1.3FL allele. Parent strains were
included as negative controls and rScl1.3FL was used as a positive control for detection. (B) Flow cytometry detection of Scl1.3FL on the GAS cell surface. Left:
Fluorescence intensity of Scl1.3FL-complemented MGAS315 WT strain was compared to vector-complemented or WT parent strain. Right: Fluorescence intensity of
Scl1.3FL-complemented MGAS10870∆scl1 was compared to WT and ∆scl1 parent strains. Median fluorescence intensities are shown in parentheses for
(Continued)
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FIGURE 7 | Continued
each strain. (C) Crystal violet assessment of bacterial biomass after 24 h of growth in cFn- or Lm-coated wells. MGAS315 WT complemented in-trans with pJRS525
(SpcR vector) or pSL502 (Table 1) harboring the scl1.3FL allele was compared to WT parental strain. Spectinomycin resistant MGAS10870∆scl1 mutant was
complemented in-trans with KanR pSL518 (Table 1), harboring the scl1.3FL allele. Biofilm biomass of the complemented strain was compared to MGAS10870 WT
and scl1-inactivated parental strains. Results represent averaged values from at least 3 independent experiments performed in triplicate wells. *P ≤ 0.05, **P ≤ 0.01,
***P ≤ 0.001; students t-test. (D,E) Confocal laser scanning microscopy analysis of biofilm formation by GFP-expressing MGAS315 vector and scl1.3FL-
complemented strains. Biofilms were grown for 24 h on cFn-coated (D) or Lm-coated (E) coverslips. Maximum intensity projections of GAS biofilms with
cross-sectional views (left panels) are representative of z-stacks from 10 fields within a single experiment. Average vertical thickness is indicated in micrometers. 3D
projections of z-stacks (right panels) are shown from the side view.
FIGURE 8 | Heterologous complementation of scl1-deficient mutant of M41-type GAS with full-length Scl1.3 restores biofilm formation. (A) Left blot:
western blot detection of full-length Scl1.3 protein in cell wall fraction of M41∆scl1::scl1.3FL using anti-Scl1 polyclonal antibody. The M41∆scl1 and M41 WT strains
were included as negative controls, and rScl1.3FL was included as a positive control. Right blot: western blot detection of Scl1.41 in M41∆scl1 and M41 WT strains
using anti-rScl1.41 antibody and rScl1.41 as a positive control. (B) Crystal violet assessment of biofilm biomass after 24 h of growth in cFn- or Lm-coated wells. M41
scl1-inactivated (M41∆scl1) mutant was complemented in-trans with either homologous scl1.41 allele harbored on pSL230 or with heterologous scl1.3FL allele
harbored on pSL502 (Table 1). M41 WT, ∆scl1 mutant and two complemented mutant strains were assessed for biofilm formation and statistical significance was
assessed by students t-test as compared to M41∆scl1; *P ≤ 0.05, **P ≤ 0.01. (C,D) Confocal laser scanning microscopy analysis of biofilm formation by
GFP-expressing M41∆scl1 or M41∆scl1::scl1.3FL. Biofilms were grown for 24 h on cFn-coated (C) or Lm-coated (D) coverslips. Maximum intensity projections of
GAS biofilms with cross-sectional views (top panels) are representative of z-stacks from 10 fields within a single experiment. Average vertical thickness is indicated in
micrometers. 3D projections of z-stacks (bottom panels) are shown from the side view.
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FIGURE 9 | Skin pathology of SKH1 hairless mice infected
subcutaneously with wild-type and scl1-inactivated mutants of M28-
and M41-type GAS. (A) Mean area of skin lesions in mice infected with M28-
or M41-type isogenic GAS strains. The severity of skin lesions was compared
following infection with wild-type (WT) or scl1-mutant (scl1) GAS; 96-h
time-point is shown. The mean lesion area and standard deviation were
calculated and compared between experimental groups. Data represents
mean lesion size from at least 10 mice per experimental group. Statistical
differences were calculated using the student’s t-test; **P ≤ 0.01, ***P ≤
0.001. (B) Gross pathology of the skin lesions. Digital images of the skin
lesions of representative animals infected with either WT or scl1-mutant GAS.
The images show skin lesions developed after 96 h post-infection, and scale
bar represents 10mm.
observation, given the abundance of IS1548 insertions across
GAS genomes representing a variety of M-types. IS elements
are known to cause genomic rearrangements and affect the
expression of important genes that contribute to bacterial
virulence (Mahillon et al., 1999). For example, the insertion
of IS1548 element (Granlund et al., 1998) into the scpB-lmb
intergenic region in group B Streptococcus has been shown
to upregulate lmb-gene transcription and Lmb-adhesin surface
expression, resulting in enhanced laminin binding (Al Safadi
et al., 2010). The IS1548 insertion in the scl1.3 promoter was
conserved in the genomes of sequenced M3 strains MGAS315,
SSI-1, and M3-b, as well as in 40 additional M3 strains
tested by PCR. However, the recently sequenced STAB902 M3
strain (Soriano et al., 2014), which represents a non-invasive
isolate, contained a 34-bp IS1548 remnant, suggesting that M3
circulating strains exist with this polymorphism. We hypothesize
that the proximity of the IS1548 insertion to the Mga I binding
site in M3 strains affects scl1.3 transcription. Comparative
qRT-PCR analysis showed significantly higher levels of scl1
transcription, particularly in M1, as well as in M28 and M41
strains, relative to M3-type strains analyzed.
Variation in the Mga coding sequence and autoregulated
mga promoter has been reported to significantly affect Mga-
dependent gene expression and virulence properties in GAS
(Flores et al., 2013; Cao et al., 2014; Sanson et al., 2015). For
example, a 12-bp deletion of a single repeat in the VNTR region
of the mga promoter is present in M3 carrier strains and absent
in the invasive M3 strains, causing a downregulation of Mga
expression and Mga-regulated genes in the carrier strains (Flores
et al., 2013). We identified an analogous 12-bp deletion in the
VNTR of the mga promoter of the M1-type MGAS5005 and in
M3 strains, MGAS335 and MGAS1313, but not in MGAS315,
MGAS158, and MGAS10870. It is likely that the variation
observed in the VNTR region impacts Mga expression but
could not, alone, explain differences in scl1 transcription patterns
observed in this work. Consequently, qRT-PCR analyses showed
mga and emm transcripts (emm is second downstream target of
Mga within the Mga regulon) were expressed at similar levels in
MGAS5005 and M3 strains, except for the MGAS335, indicating
a mechanism of scl1 downregulation in M3 strains, which is
independent from the level of Mga transcription. The presence
of emm transcripts andM3-protein products indicate that Mga is
present and functional in the majority of M3 strains tested, and
therefore the polymorphism we observed in the mga promoter
did not affect Mga expression or activity of Mga-controlled scl1.3
promoter. Altogether, our data hint at the insertion of the IS1548
in the downregulation of scl1.3 expression, specifically in M3-
type GAS, although additional studies are required to firmly
establish whether the IS element insertion is responsible.
It is intriguing that scl1 and scl2 expression patterns were
drastically different between M1 and M3-type GAS, both
associated with invasive infections. The scl1.3 transcript was
decreased by 21-fold in MGAS315, and even further in the
remaining M3 strains studied (additional 20- to 45-fold), as
compared to the M1-type strain MGAS5005. The upregulation
of scl1 in M1-type GAS has previously been shown in invasive
M1 isolates, including MGAS5005, as compared to pharyngeal
M1 isolates (Sumby et al., 2006). Studies comparing wild-type
and isogenic scl1.1 mutants in M1-type GAS reported that
Scl1.1 contributed to immune evasion by inhibiting neutrophil
extracellular trap production and by protecting bacteria from the
cathelicidin LL-37 (Döhrmann et al., 2014). We conclude the
differences we observed in scl1 expression are related to different
pathogenicity requirements for Scl1 protein in M1- vs. M3-type
strains. In contrast, Scl2 expression is highly upregulated in M3-
type strains, as compared to invasive M1-type GAS. While the
majority of M3-type strains contain in-frame scl2.3 alleles, all
21 M1 strains we analyzed contained out-of-frame scl2.1 alleles
(unpublished data). Although, the Scl2.3 human ligands are not
known, it may have an unidentified biological function, which is
important for pathogenesis of M3, but not M1, strains. Hence, we
are reporting striking differences in the expression and features of
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FIGURE 10 | Model of Scl1-mediated GAS adhesion, biofilm formation, and host colonization. M28- and M41-type GAS express full-length cell-attached
Scl1, which mediates adherence to cFn and Lm. ECM binding promotes biofilm formation in wounded tissue and allows the formation of superficial tissue
microcolonies resulting in non-invasive colonization. On the contrary, in M3-type GAS, naturally lacking full-length cell-attached Scl1.3 adhesin, bacterial cells have
reduced adherence to cFn and Lm and reduced capacity for biofilm formation, thereby circumventing the formation of localized tissue microcolonies; infection balance
is shifted toward dissemination through tissue, promoting invasive spread.
the Scl1 and Scl2 proteins that evolved in the invasiveM1 andM3
strains.
Scl1-Mediated Adhesion and Biofilm
Formation In vitro
Scl1 mediates binding to human extracellular matrix
components, cellular fibronectin and laminin, as well as biofilm
formation (Caswell et al., 2010; Oliver-Kozup et al., 2011, 2013).
Previous work identified that Scl1 binds specifically to the C-C′
loop of the type III-repeat EDA domain of cellular fibronectin
(Oliver-Kozup et al., 2013). This represents a novel mechanism
of fibronectin binding, which is distinct from the mechanism
employed by other GAS fibronectin-binding proteins that bind
to the N-terminal type I repeats of fibronectin (Yamaguchi et al.,
2013). Here, we determined that rScl1.3FL binds to cellular
fibronectin via the same C-C′ loop-dependent mechanism. It
is important for our overall model to acknowledge that the
EDA-cFn isoform is specifically produced during embryogenesis
and during wound healing in adult tissue (Ffrench-Constant
et al., 1989; Jarnagin et al., 1994; Singh et al., 2004), which
indicates Scl1 evolved with a unique function for targeting
wounded tissue, a presumed pathogen portal of entry. We
also demonstrate significant binding of rScl1.3FL to laminin,
a major basement membrane protein at the epidermal-dermal
junction; none of those ECM ligands were bound by rScl2.3,
consistent with previous knowledge that Scl1, but not Scl2,
variants exhibit binding to cFn and Lm (Caswell et al., 2010).
These studies show that full-length Scl1.3, if expressed on the
M3-GAS cell surface, would bind ECM, contributing to tissue
colonization.
The diminished Scl1.3 expression and poor biofilm formation,
led us to hypothesize that lack of surface-expressed Scl1 in M3-
type GAS reduces host ECM binding and stable microcolony
formation in tissue, thus, shifting the balance toward invasive
spread, augmented by other virulence factors expressed by
these strains. Recombinant rScl1.3FL formed aggregates that
were mediated by the V-to-V region interactions, which
could represent a mechanism of biofilm and microcolony
stabilization by Scl1 molecules on adjacent GAS cells. Two
representative invasive M3 isolates, MGAS315 and MGAS10870,
acquired biofilm formation on cFn and Lm when homologous
complementation was performed with surface-attached Scl1.3FL.
MGAS315 has been shown to contain a missense mutation in
the covS gene, causing upregulation of CovRS-regulated virulence
genes and enhanced virulence during subcutaneous infection of
mice, compared to an isogenic strain containing the WT covS
allele (Stetzner et al., 2015). Additionally, MGAS315 contains
a mutation in the regulator of protein B allele, ropB, which
produces a nonfunctional RopB variant, while MGAS10870
contains a wild-type covR/S and ropB alleles (Carroll et al., 2011),
allowing us to demonstrate the effect of Scl1.3FL function in the
presence of differing regulatory networks. Similarly, heterologous
complementation with surface Scl1.3FL in a scl1.41-mutant of
the non-invasive biofilm-capable strain M41-type MGAS6183,
restored its biofilm capacity to the wild-type level. These results
indicate that M3-derived Scl1.3FL variant has the full capacity
to support biofilm formation to a similar degree as Scl1 from a
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divergent M-type. The robust biofilm observed in vitro on ECM
coatings validates the concept that biofilm capacity combined
with adherence to the surrounding host ECMwould reinforce the
formation of stable tissue microcolonies in vivo.
In vitro Skin Equivalent Model of Wound
Colonization and Microcolony Formation
We observed inhibition of wound re-epithelization by GAS
infection of wounded skin equivalents, as well as the thinning
of the viable epidermal layer at sites distant from the infected
wound. In addition to our study, others have reported changes in
skin histopathology and wound healing, resulting from bacterial
infections. An in vivo study has reported epidermal defects as
a result of GAS infection in a humanized mouse model with
human skin graft (Scaramuzzino et al., 2000). Previous study of
M3-type GAS infection using a skin equivalent model showed
that hyaluronic acid capsule interactions with CD44 receptor
on keratinocytes induced intracellular signaling, resulting in
cytoskeletal rearrangement and monolayer disruption (Cywes
and Wessels, 2001). Infection of an in vitro skin model
containing a burn wound with Pseudomonas aeruginosa caused
a loss of the keratinocyte layer and basement membrane, while
intact epidermis was observed in burned but uninfected tissue
(Shepherd et al., 2009). Impairment of wound healing has also
been demonstrated by staphylococcal infections. Infection of
dermal wounds in rabbit ears with Staphylococcus aureus showed
the formation of biofilm, production of a persistent, low grade
inflammatory response, and significantly delayed wound healing
(Gurjala et al., 2011). Similarly, delayed wound healing by both
S. aureus and S. epidermidis biofilms was observed in a mouse
model of cutaneous wounds (Schierle et al., 2009). The inhibition
of wound healing we describe here is by and large consistent with
reports by other laboratories generated using in vivo animal and
in vitro human skin infection models.
Microcolonies have been identified within human
streptococcal impetigo lesions (Akiyama et al., 2003) and
in tonsils from patients with recurrent GAS pharyngeal tonsillitis
(Roberts et al., 2012), and likely represent a superficial or
persistent state of GAS colonization. However, streptococcal
infections can result in invasive disease due to biofilm disruption
and bacterial dissemination (Connolly et al., 2011a,b). We
observed large rounded microcolonies formed in tissue during
infection with M41 strain, while M3 GAS remained scattered
throughout the tissue as single cells and chains. Microcolony
formation has been previously observed with S. aureus infection
in organotypic skin model (Popov et al., 2014). Moreover, wound
infection in rabbit ears with S. aureus produced mature biofilms
encased in exopolysaccharide, as revealed by concanavalin A
staining (Gurjala et al., 2011). Similarly, we also demonstrated
that microcolonies in M41-infected tissue were encapsulated in
bacterial-associated glycocalyx. However, a lack of glycocalyx-
encapsulated microcolonies was associated with infection by
M3-type GAS.
These results support our hypothesis that biofilm-poor M3
strains are abolished in stable microcolony formation in vivo, in
part due to a lack of the ECM-binding Scl1 protein and an overall
lack of surface adhesins, although they likely express the FbaB
protein, identified inM3GAS to be involved in the adherence and
invasion into epithelial and endothelial cells (Terao et al., 2001,
2002; Amelung et al., 2011).
In vivo Mouse Model of Skin Infection
Recent study reported that a small proportion of non-invasive
M3-type strains (∼1.3%) were found to harbor the scl1.3
“carrier allele,” which resulted from an in-frame deletion in the
collagenous region, encompassing the null mutation, producing
a shorter cell-attached Scl1.3 variant. This MGAS10870 strain
containing the scl1.3 carrier allele was attenuated following
intramuscular infection (Flores et al., 2015). In this study, we
utilized the M28- and M41-type strains, representing biofilm-
rich producers, for subcutaneous inoculation. We observed
that scl1.28- and scl1.41-inactivated isogenic mutants produced
significantly larger skin lesions as compared to the wild-type
parent strains. These results, again, support the hypothesis
that lack of Scl1 surface adhesin destabilizes focused nidus of
infection, resulting in a shift toward increased tissue spread.
However, previous studies performed in a M1 GAS background,
utilizing scl1.1-mutants for subcutaneous infection, reported
smaller skin lesions in the mutant groups, which likely reflects
a differing predominant function of Scl1.1 in M1-type GAS
(Lukomski et al., 2000; Döhrmann et al., 2014). Investigations
using intranasal and intraperitoneal mouse infection models
of Streptococcus pneumoniae have shown that culture-grown
bacteria disseminated to the ear and lungs, while biofilm-
grown bacteria stably colonized the nasopharynx (Blanchette-
Cain et al., 2013; Marks et al., 2013). A similar study on
Streptococcus pyogenes showed that bacteria grown in biofilms
have downregulated virulence genes and tend to colonize the
nasal associated lymphoid tissue of mice, while culture-grown
bacteria had significantly increased dissemination and were more
virulent in a septicemia model (Marks et al., 2014). Previous
studies reported that inactivation of some GAS genes resulted
in increased skin pathology produced by the mutants compared
to their wild-type organisms, and these genes often encoded
surface proteins, including SpyCEP (Sumby et al., 2008), Mrp
(Boyle et al., 1998), protein F1 (Nyberg et al., 2004), and Spy0128,
encoding a major pilus subunit (Crotty Alexander et al., 2010).
Similarly, the covS mutant of group A streptococcal M1T1
strain with upregulated SpeB-protease activity was hypervirulent
and had reduced capacity to bind human epithelial cells and
fibronectin, and also to form biofilm due to increased cleavage of
surface proteins (Hollands et al., 2010). Altogether, the concept
that expression of a surface adhesin, such as Scl1, involved in
biofilm formation and host tissue attachment, is inversely related
to strain invasiveness has gained support from several studies,
including this study.
We show the invasive M1- and M3-type GAS evolved
scl1 and scl2 alleles with opposite expression patterns, with
scl1 downregulated and scl2 upregulated in M3 compared
to M1 GAS. We show M3-type GAS, devoid of surface-
expressed Scl1.3, lacked biofilm formation on ECM coatings and
microcolony formation during infection of in vitro wounded
skin equivalent. Complementation with surface Scl1.3FL restored
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biofilm capacity of M3-type GAS on ECM coatings. Mouse
infection with the isogenic scl1mutants of biofilm-rich M28- and
M41-type GAS produced larger lesions, supporting the role of
Scl1 in a localized tissue infection. Lastly we developed a model
for Scl1-mediated microcolony formation (Figure 10), whereby
Scl1 expressed on the GAS surface strengthens host colonization
by attachment to cFn and Lm expressed within wounded tissue,
as well as biofilm formation via Scl1-Scl1 interactions, resulting
in a local, stabilizedmicrocolony. Conversely, when Scl1 is absent
on the GAS cell surface, as is the case for M3-type GAS, bacteria
lack stable anchoring in the surrounding host ECM, as well
as structural strength within microcolony, promoting cells to
disperse more freely.
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